TrialThe AAPS journal2012

Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic pain.

Sandeep Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.